Deanna L. Kirkpatrick

Davis Polk advised InflaRx N.V. on its $100 million initial public offering of 6,667,000 of its common shares. In addition, InflaRx has granted the underwriters a 30-day option to purchase…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.7 billion aggregate principal amount of its 1.900% senior notes due 2019 and (ii) $300 million…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 2.20% bonds due October 3, 2022, issued by the Province of Ontario. The…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $1 billion aggregate principal amount of its 1.850% senior notes due 2020, under its $40 billion medium…

Davis Polk advised the underwriters in connection with the offering of C$500 million aggregate principal amount of 1.800% Canadian dollar bonds due 2022 issued by Export Development…

Davis Polk advised the joint book-running managers in connection with the initial public offering of 40,250,000 units of Capitol Investment Corp. IV, including 5,250,000 units…

Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary shares of Oxford Immunotec Global PLC. The ordinary shares are…

Davis Polk advised DXC Technology Company on its SEC-registered offering of $650 million aggregate principal amount of senior floating-rate notes due 2021.  DXC is an end-to-end IT…

Davis Polk advised DXC Technology Company in connection with its registered exchange offers of (i) up to $445.265 million aggregate principal amount of DXC’s new 4.45% senior notes due 2022…

Davis Polk advised the dealer manager on Ciena Corporation’s offer to exchange up to $350 million aggregate principal amount at maturity of outstanding 3.75% convertible senior notes…